Clinical trials
Completed trials in Tunisia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
145 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 12 |
| 2020 | 17 |
| 2021 | 12 |
| 2022 | 7 |
| 2023 | 14 |
| 2024 | 23 |
| 2025 | 15 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 145 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Tunis El Manar | 28 |
| University of Monastir | 17 |
| Mongi Slim Hospital | 7 |
| The Higher Institute of Sport and Physical Education of Sfax | 7 |
| Tunis University | 7 |
| High Institute of Sports and Physical Education of Kef | 6 |
| Faculty of Medicine, Sousse | 5 |
| Hopital Charles Nicolle | 5 |
| Gynuity Health Projects | 4 |
| Military Hospital of Tunis | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Pain | 12 |
| Agnosia | 8 |
| Obesity | 8 |
| Pain | 8 |
| Anxiety Disorders | 6 |
| Inflammation | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| COVID-19 | 4 |
| Acute Pain | 3 |
| Hip Fractures | 3 |
Trials
Showing 1 to 25 of 145. Each trial links to its page on Pharma Observatory.
45 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.